CCRN
CROSS COUNTRY HEALTHCARE INC
Next earnings Aug 4, 2026 (after close) · consensus $0.00 EPS, $248M rev
Last earnings +29.5% on 2026-05-07
$13.22
▲ +0.23%$13.22▼ -0.60%
over 1Y
L $7.53EODHDH $14.23
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+0.2%
1W+0.4%
1M+1.1%
3M+38.9%
YTD+64.0%
1Y-0.6%
Avoid
Conviction
Horizon
Medium (3–12mo)
Street · 14 analysts
Hold
Conservative balance sheet (liabilities/equity 0.39x); but revenue fell -21.6% YoY.
Revenue (FY2025) $1.05B · FY2025
CROSS COUNTRY HEALTHCARE INC shows $1.05B in FY2025 revenue (-21.6% YoY), a -9.0% net margin, and -29.4% ROE.
Financials · annual, by fiscal year
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $1.68B | $2.80B | $2.02B | $1.34B | $1.05B |
| Gross profit | — | — | — | — | — |
| Operating income | $139M | $270M | $113M | -$16.9M | -$84.4M |
| Net income | $132M | $186M | $72.6M | -$14.6M | -$94.9M |
| Diluted EPS | $3.53 | $4.95 | $2.05 | -$0.44 | -$2.93 |
| Net margin | 7.9% | 6.6% | 3.6% | -1.1% | -9.0% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$469M
EV / EBITDA—
EV / Sales0.4
EV / FCF11.7
P / FCF10.7
PEG (trailing)—
Earnings yield-22.2%
FCF yield9.4%
Quality & risk
ROIC (est.)-14.1%
Free cash flow$40.1M
Total debt$151M
Net cash-$41.9M
Altman Z-Score4.72 safe
Piotroski F-Score5/8
Capital returns
Buyback yield1.6%
Dividend yield (est.)—
Shareholder yield1.6%
Shares Δ YoY-1.5%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsSome governance/structural items recently, but no outright red flags.
Recent filings
all on EDGAR ↗8-KPeriod ending 2026-06-222026-06-23open ↗DEFM14AFiling2026-06-15open ↗PREM14APeriod ending 2026-06-032026-06-03open ↗SCHEDULE 13GFiling2026-05-14open ↗10-QPeriod ending 2026-03-312026-05-08open ↗DEFA14AFiling2026-05-07open ↗DEFA14AFiling2026-05-07open ↗DEFA14AFiling2026-05-07open ↗8-KPeriod ending 2026-05-072026-05-07open ↗DEFA14AFiling2026-05-07open ↗8-KPeriod ending 2026-05-062026-05-07open ↗8-KPeriod ending 2026-04-172026-04-17open ↗
Frequently asked
- Is CROSS COUNTRY HEALTHCARE INC (CCRN) a buy?
- CCRN currently carries a Avoid rating with 4/5 conviction, derived from its latest SEC filings. Conservative balance sheet (liabilities/equity 0.39x); but revenue fell -21.6% YoY.
- What is CROSS COUNTRY HEALTHCARE INC's quality score?
- CCRN scores 47.3921568627451/100 (grade D) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001141103, latest 10-Q filed 2026-05-08) · EODHD · as of 6/26/2026, 6:59:01 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.